Literature DB >> 22724048

Allelic and genotype frequencies of catechol-O-methyltransferase (Val158Met) and CYP2D6*10 (Pro34Ser) single nucleotide polymorphisms in the Philippines.

Michael O Baclig1, Rey Z Predicala, Cynthia A Mapua, Jingky P Lozano-Kühne, Maria Luisa G Daroy, Filipinas F Natividad, Francis O Javier.   

Abstract

A hospital-based cross-sectional study was conducted to determine the allelic and genotype frequencies in the genes encoding for catechol-O-methyltransferase and CYP2D6*10 among healthy volunteers and patients clinically diagnosed with cancer pain. PCR-RFLP was used to identify COMT and CYP2D6*10 genotypes. Allelic frequencies among healthy volunteer Filipinos were 0.83 and 0.17 for the COMT Val and COMT Met alleles, respectively. Calculated frequencies in Hardy-Weinberg equilibrium (HWE) were 73% for COMT Val/Val, 26% for COMT Val/Met, and 1% for COMT Met/Met genotype. For CYP2D6*10, allelic frequencies in HWE among volunteers were 0.46 for the C allele and 0.54 for the T allele. Twenty percent were identified as homozygous for the wild-type C/C genotype, 56% were identified as heterozygous for the C/T genotype, and 24% were identified as homozygous for the T/T variant genotype. No significant differences in COMT and CYP2D6*10 allele frequencies between cancer patients and healthy volunteers were noted. Our data demonstrated that the allele frequencies of COMT and CYP2D6*10 in the Filipino healthy volunteers were similar with other Asians but markedly different from Caucasian populations.

Entities:  

Keywords:  Allele frequency; CYP2D6*10; Filipino; catechol-O-methyltransferase; polymorphism

Year:  2012        PMID: 22724048      PMCID: PMC3376921     

Source DB:  PubMed          Journal:  Int J Mol Epidemiol Genet        ISSN: 1948-1756


  35 in total

1.  CYP2D6 polymorphism in a Mexican American population.

Authors:  R Mendoza; Y J Wan; R E Poland; M Smith; Y Zheng; N Berman; K M Lin
Journal:  Clin Pharmacol Ther       Date:  2001-12       Impact factor: 6.875

2.  CYP2D6 genetic polymorphism in South Indian populations.

Authors:  Amrithraj Theophilus Naveen; Chandrasekaran Adithan; Sisy Sam Soya; Nathalie Gerard; Rajagopal Krishnamoorthy
Journal:  Biol Pharm Bull       Date:  2006-08       Impact factor: 2.233

3.  Frequency of CYP2D6*10 and *14 alleles and their influence on the metabolic activity of CYP2D6 in a healthy Chinese population.

Authors:  W M Cai; B Chen; W X Zhang
Journal:  Clin Pharmacol Ther       Date:  2007-01       Impact factor: 6.875

4.  Polymorphisms of catechol-O-methyltransferase in men with renal cell cancer.

Authors:  Yuichiro Tanaka; Hiroshi Hirata; Zhong Chen; Nobuyuki Kikuno; Ken Kawamoto; Shahana Majid; Takashi Tokizane; Shinji Urakami; Hiroaki Shiina; Koichi Nakajima; Rajiv Dhir; Rajvir Dahiya
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-01       Impact factor: 4.254

5.  CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer status.

Authors:  Andrea Gaedigk; L Dianne Bradford; Sarah W Alander; J Steven Leeder
Journal:  Drug Metab Dispos       Date:  2006-01-13       Impact factor: 3.922

6.  Genetic matters of CYP2D6 in breast cancer: copy number variations and nucleotide polymorphisms.

Authors:  Ke-Da Yu; Zhi-Ming Shao
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

7.  Genetic analysis of the CYP2D6 locus in a Hong Kong Chinese population.

Authors:  M Garcia-Barceló; L Y Chow; H F Chiu; Y K Wing; D T Lee; K L Lam; M M Waye
Journal:  Clin Chem       Date:  2000-01       Impact factor: 8.327

8.  Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles.

Authors:  E Aklillu; I Persson; L Bertilsson; I Johansson; F Rodrigues; M Ingelman-Sundberg
Journal:  J Pharmacol Exp Ther       Date:  1996-07       Impact factor: 4.030

9.  COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor.

Authors:  Jon-Kar Zubieta; Mary M Heitzeg; Yolanda R Smith; Joshua A Bueller; Ke Xu; Yanjun Xu; Robert A Koeppe; Christian S Stohler; David Goldman
Journal:  Science       Date:  2003-02-21       Impact factor: 47.728

10.  Individualized pain medicine.

Authors:  Hyungsuk Kim; Raymond A Dionne
Journal:  Drug Discov Today Ther Strateg       Date:  2009
View more
  6 in total

1.  Association of single nucleotide polymorphisms of ABCB1, OPRM1 and COMT with pain perception in cancer patients.

Authors:  Xu-Shi Wang; Hai-Bin Song; Si Chen; Wei Zhang; Jia-Qi Liu; Chao Huang; Hao-Ran Wang; Yuan Chen; Qian Chu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

2.  Catechol-O-methyltransferase polymorphism Val158Met is associated with distal neuropathic pain in HIV-associated sensory neuropathy.

Authors:  Jennie Xu; Anya Umlauf; Scott Letendre; Donald Franklin; William S Bush; Joseph H Atkinson; John Keltner; Ronald J Ellis
Journal:  AIDS       Date:  2019-08-01       Impact factor: 4.632

3.  Dopamine in socioecological and evolutionary perspectives: implications for psychiatric disorders.

Authors:  Yoshie Yamaguchi; Young-A Lee; Yukiori Goto
Journal:  Front Neurosci       Date:  2015-06-16       Impact factor: 4.677

4.  Relationship between CYP2D6 genotype, activity score and phenotype in a pediatric Thai population treated with risperidone.

Authors:  Yaowaluck Hongkaew; Andrea Gaedigk; Bob Wilffert; Nattawat Ngamsamut; Wiranpat Kittitharaphan; Penkhae Limsila; Chonlaphat Sukasem
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

5.  COMTVal158Met polymorphism is associated with ecstasy (MDMA)-induced psychotic symptoms in the Turkish population.

Authors:  Hasan Mervan Aytac; Yasemin Oyaci; Pinar Cetinay Aydin; Mustafa Pehlivan; Sacide Pehlivan
Journal:  Neurosciences (Riyadh)       Date:  2022-01       Impact factor: 0.735

6.  Genetic polymorphisms analysis of CYP2D6 in the Uygur population.

Authors:  Xue He; Na He; Lisong Ren; Yongri Ouyang; Ning Zhang; Yini Ma; Dongya Yuan; Longli Kang; Tianbo Jin
Journal:  BMC Genomics       Date:  2016-05-26       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.